Clinical Trials for the Nonsecretory Myeloma Patient with Dr. Sascha Tuchman
Clinical Trials for the Nonsecretory Myeloma Patient with Dr. Sascha Tuchman image
May 17, 2022 / 07:00PM - 08:00PM EDT
Non-Secretory Myeloma Community Chapter

Event Description

Are there any clinical trials that are currently open for non-secretory patients? Why aren't they allowed to participate in the majority of clinical trials? Will clinical trial requirements change in the future so that they can start participating?

Schedule & Agenda

person
Introduction
07:00PM
Audrey Burton-Bethkee
Audrey introduces the agenda of the event and featured speaker Dr. Sascha Tuchman
person
Presentation
07:05PM
Dr. Sascha Tuchman
Dr. Tuchman talks about clinical trials for non-secretory myeloma patients.
person
Questions and Answers
07:35PM
Audience
Type your questions in the chat and we will answer them!

Speakers & Moderators

The panelist Audrey Burton-Bethke
Audrey Burton-Bethke

Audrey joined the Myeloma Crowd as the Community Program Director in 2020. While not knowing much about myeloma at the start, she has since worked hard to educate herself, empathize and learn from others' experiences. She loves this job. Audrey is passionate about serving others, loves learning, and enjoys a nice mug of hot chocolate no matter the weather.

Read Bio
The panelist Dr. Sascha Tuchman
Dr. Sascha Tuchman

Dr. Tuchman is a board-certified medical oncologist and divides his time between clinical care and clinical research. He studies and treats all forms of plasma cell disorders but has a special research interest in amyloidosis, and in managing older, frail patients with multiple myeloma. He has years of experience in managing patients and leading research efforts in these disorders, and he directs the multiple myeloma and amyloidosis program at UNC. As part of that role, he mentors the research and career development of trainees who have an interest in myeloma and related conditions. Outside UNC, Dr. Tuchman sits on expert groups that design research in and formulate guidelines for managing plasma cell disorders, such as the International Myeloma Working Group, the International Society for Amyloidosis, and the multiple myeloma committee in the Alliance cooperative cancer research group. When not at work, he enjoys playing ice hockey, cycling, playing music, studying languages, reading history, and spending time with his family including his wife and three sons.

Read Bio

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

+1 800 709 1113

email

Support@healthtree.org

Get the latest thought leadership on Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.

Thanks to our HealthTree Community for Myeloma Sponsors:

Bristol Myers Squibb
Abbvie
Genentech
GSK
Janssen Oncology

Follow Us

facebook instagram twitter youtube

Copyright © 2022 HealthTree Foundation. All Rights Reserved.

The HealthTree Foundation for Multiple Myeloma (formerly know as Myeloma Crowd) is a qualified 501(c)(3) tax-exempt organization. Tax ID 45-5354811

 https://www.guidestar.org/profile/45-5354811